Steak vs. shake: which protein builds more muscle?
NCT ID NCT06739408
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at whether getting protein from whole food (lean red meat) is better than from a supplement (whey protein) for building muscle during resistance training. 81 healthy adults did a 12-week exercise program and had either lean red meat, whey protein, or a placebo drink after each session. Researchers measured changes in muscle strength and body composition to see if protein source matters.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lean red meat, whey protein, or maltodextrin placebo
- What this could lead to
- If it works, this could show that whole food protein like lean red meat is just as good as supplements for building muscle with exercise.
- What could go wrong
- This is a small, completed study in healthy young adults, so results may not apply to older people or those with health conditions. It also does not test any disease treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Human Nutrition Studies Unit, University College Cork
Cork, Co. Cork, T12 CY82, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test